Thomas G P
Department of Pharmacology, IDPL Research Centre, Hyderabad, India.
Eur J Pharmacol. 1995 Apr 4;276(3):215-21. doi: 10.1016/0014-2999(95)00025-g.
Azepexole, an alpha 2-adrenoceptor agonist (125, 250 and 500 micrograms/kg i.v.), was examined for its effect on ouabain-induced ventricular premature beats, ventricular tachyarrhythmias and lethality in guinea-pigs. The doses of ouabain required to cause ventricular arrhythmias and lethality were significantly higher in azepexole-treated animals. However, it did not offer any protection in reserpinised guinea-pigs. Idazoxan, the alpha 2-adrenoceptor antagonist (100 micrograms/kg i.v.) inhibited the protective action of azepexole while corynanthine, the alpha 1-adrenoceptor antagonist (1 mg/kg i.v.), potentiated the effect. Azepexole inhibited the rate of the ouabain-induced rise in mean arterial blood pressure and the peak pressor response. In isolated paced left atria of guinea-pig, azepexole (2.76 x 10(-3) M) did not offer any protection against extrasystolic contractions induced by ouabain. Therefore the protective effect of azepexole may be mediated through the stimulation of alpha 2-adrenoceptors and the resultant suppression of the indirect neural components of ouabain toxicity.
阿泽哌唑是一种α2肾上腺素能受体激动剂(静脉注射剂量为125、250和500微克/千克),研究了其对哇巴因诱导的豚鼠室性早搏、室性心律失常和致死率的影响。在接受阿泽哌唑治疗的动物中,引发心律失常和致死所需的哇巴因剂量显著更高。然而,它对利血平化的豚鼠没有提供任何保护作用。α2肾上腺素能受体拮抗剂伊达唑胺(静脉注射剂量为100微克/千克)抑制了阿泽哌唑的保护作用,而α1肾上腺素能受体拮抗剂育亨宾(静脉注射剂量为1毫克/千克)则增强了这种作用。阿泽哌唑抑制了哇巴因诱导的平均动脉血压升高速率和升压反应峰值。在豚鼠离体起搏左心房中,阿泽哌唑(2.76×10−3 M)对哇巴因诱导的期外收缩没有提供任何保护作用。因此,阿泽哌唑的保护作用可能是通过刺激α2肾上腺素能受体以及由此抑制哇巴因毒性的间接神经成分来介导的。